Measurement of Cancer-Related Risk Perception in Smokers
NCT ID: NCT00588211
Last Updated: 2022-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1514 participants
OBSERVATIONAL
2001-09-30
2022-09-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Young Adults' Responses to Anti-smoking Messages
NCT01954407
Alcohol Cessation Among Head and Neck Cancer Survivors
NCT05570851
Motivating a Spectrum of Cancer Patients to Quit Smoking
NCT04914000
Smoking Cessation Intervention for Cancer Patients
NCT00575718
Smoking Relapse-Prevention Intervention for Cancer Patients
NCT01630161
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
We will recruit fifteen New York University College of Dentistry (NYUCD) clinic patients who report current tobacco use.
Interviews
45-minute individual interviews after the conclusion of their dental appointment
2
Second, we will recruit thirty dental clinic smokers (10 per day for 3 days) from the NYUCD waiting room.
focus group
A focus group of the preliminary cancer-related risk perception item pool.
3
Third, we will survey 200 student participants from Adelphi University.
Survey
Quantitative item analysis of the final item pool.
4
Queens Hospital Center with 800 patients.
Survey
A second confirmatory factor analysis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interviews
45-minute individual interviews after the conclusion of their dental appointment
focus group
A focus group of the preliminary cancer-related risk perception item pool.
Survey
Quantitative item analysis of the final item pool.
Survey
A second confirmatory factor analysis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* For recruitment at Adelphi University: Speak English
* For recruitment at Queens Hospital Center: Speak English
* For recruitment at Queens Hospital Center: Must be a Queens Hospital Center Patient
Exclusion Criteria
* Patients who cannot give informed consent
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Adelphi University
OTHER
Queen's Hospital Center
OTHER
Memorial Sloan Kettering Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer L Hay, PhD
Role: PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Queens Hospital Center
Jamaica, New York, United States
New York University, College of Dentistry
New York, New York, United States
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
Adelphi University
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Memorial Sloan-Kettering web site
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CA93182
Identifier Type: -
Identifier Source: secondary_id
01-121
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.